Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Norfolk › NPI 1447305032
Clinic

Childrens Hospital of the Kings Daughters INC

Childrens Hospital of the Kings Daughters INC was paid $10.18M by Medicaid between Jan 2018 and Jun 2024, across 159 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 25% of everything it billed.

33Billing provider infoCHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
NORFOLK, VA 23507
33aNPI1447305032assigned 01/24/2007
28Total paid$10.18M
24GClaims348,990
24DCodes billed159
24AFirst – last monthJan 2018 – Jun 2024
Compared with peers

Next to other Adolescent and Children Mental Health Clinic/Center providers in Virginia

Rank by total paid#2 of 16
Median peer was paid$211K
This provider vs. median48×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201831,539$424K
201977,507$1.44M
202071,446$2.63M
202189,740$2.94M
202277,150$2.60M
20231,405$124K
2024incomplete203$23K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
97530 Therapeutic activities, direct patient contact, each 15 minutes 25% 41,844 13,544 $2.52M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 18% 19,838 19,284 $1.85M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 16% 36,589 10,338 $1.65M
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 7.6% 23,646 7,659 $778K
J0585 Injection, onabotulinumtoxina, 1 unit 5.7% 256 231 $582K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.4% 6,602 6,447 $450K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 3.5% 2,426 2,370 $358K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.6% 4,814 1,957 $159K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.5% 1,509 1,485 $150K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 1.0% 1,031 1,009 $105K
97161 <1% 1,981 1,923 $99K
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation <1% 876 795 $97K
147 more codes
90837 Psychotherapy session, about an hour <1% 1,016 $95K
97162 <1% 1,820 $91K
90834 Psychotherapy session, about 45 minutes <1% 1,279 $89K
92526 <1% 1,420 $85K
97535 Self-care/home management training, each 15 minutes <1% 2,288 $76K
92587 <1% 3,298 $70K
92579 <1% 1,421 $64K
97116 <1% 2,612 $62K
97542 <1% 927 $61K
92567 <1% 3,859 $58K
97165 <1% 1,342 $58K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 5,757 $46K
99215 Doctor's office visit, returning patient (complex) <1% 331 $41K
64643 <1% 296 $32K
64642 <1% 305 $32K
97760 <1% 381 $27K
97016 <1% 966 $25K
87631 <1% 4,687 $25K
90832 Psychotherapy session, about 30 minutes <1% 402 $20K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 3,926 $17K
94010 <1% 1,807 $15K
97763 <1% 573 $15K
97014 <1% 670 $14K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,673 $12K
96112 <1% 65 $10K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 129 $10K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 14,832 $9K
80053 Comprehensive metabolic panel <1% 8,018 $9K
93304 <1% 276 $9K
80050 General health panel <1% 3,277 $9K
96127 <1% 1,365 $8K
99205 Prolong outpt/office vis <1% 53 $8K
97010 <1% 4,238 $8K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,845 $7K
93321 <1% 938 $6K
87486 <1% 4,688 $6K
87581 <1% 4,690 $6K
93325 <1% 2,021 $6K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 141 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 7,222 $5K
92552 <1% 169 $5K
80061 Lipid panel <1% 6,713 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,076 $5K
87507 <1% 380 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,098 $5K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 76 $5K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 807 $4K
84443 Thyroid stimulating hormone (TSH) <1% 2,860 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,969 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 6,300 $4K
96160 <1% 1,170 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,126 $3K
84439 <1% 4,706 $3K
92556 <1% 80 $3K
83020 <1% 1,032 $3K
82728 <1% 2,295 $3K
97033 <1% 112 $3K
97750 <1% 30 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 59 $2K
95117 <1% 178 $2K
93227 <1% 98 $2K
97755 <1% 12 $2K
V5266 Battery for use in hearing device <1% 269 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,296 $2K
82248 <1% 2,731 $2K
87077 <1% 1,847 $2K
83516 <1% 1,825 $2K
85045 <1% 2,525 $2K
82977 <1% 2,655 $2K
80306 <1% 1,019 $2K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 13 $2K
99170 <1% 13 $2K
83735 <1% 1,028 $2K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 23 $1K
82784 <1% 1,948 $1K
82570 <1% 2,401 $1K
84100 <1% 1,249 $1K
96111 <1% 13 $1K
80048 Basic metabolic panel (calcium, ionized) <1% 1,076 $1K
82043 <1% 1,606 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,472 $1K
V5011 Fitting/orientation/checking of hearing aid <1% 14 $1K
86003 <1% 574 $1K
99283 Emergency room visit (moderate) <1% 19 $983.34
87186 <1% 1,275 $939.74
83550 <1% 807 $891.00
84460 <1% 747 $855.95
82247 <1% 1,882 $839.65
83540 <1% 1,038 $828.14
84450 <1% 745 $785.00
82565 <1% 577 $709.39
85027 <1% 1,017 $702.88
81025 <1% 986 $682.00
84146 <1% 348 $587.16
86140 <1% 2,719 $554.87
81001 <1% 2,075 $530.45
81003 <1% 3,201 $529.71
83655 <1% 4,206 $519.19
87070 <1% 863 $517.02
87506 <1% 14 $473.38
80076 <1% 548 $433.68
83001 <1% 343 $372.05
85610 <1% 571 $367.87
85652 <1% 2,661 $325.38
83970 <1% 24 $297.20
85007 <1% 656 $287.42
86480 <1% 105 $278.90
87660 <1% 277 $266.82
87480 <1% 277 $252.70
87510 <1% 277 $252.70
90785 <1% 18 $237.24
86038 <1% 422 $217.67
83002 <1% 291 $216.71
87101 <1% 331 $208.20
84156 <1% 750 $204.96
83615 <1% 157 $202.48
84550 <1% 364 $195.36
84402 <1% 163 $160.44
86592 <1% 1,395 $109.28
85730 <1% 155 $100.97
83690 <1% 258 $81.29
83519 <1% 13 $66.24
80197 <1% 15 $49.44
82465 <1% 260 $39.20
86803 <1% 67 $38.52
87340 <1% 75 $37.20
83993 <1% 17 $35.34
82785 <1% 115 $32.92
85018 <1% 908 $31.95
80324 <1% 25 $27.28
82670 <1% 119 $25.15
82150 <1% 114 $17.49
86665 <1% 13 $16.33
82947 <1% 24 $14.16
87807 <1% 74 $11.79
86706 <1% 67 $9.67
82272 <1% 17 $7.62
82550 <1% 29 $5.86
85660 <1% 12 $4.96
J2357 Injection, omalizumab, 5 mg <1% 15 $0.16
36415 Collection of venous blood by venipuncture 0% 58 $0.00
97113 0% 50 $0.00
82607 0% 13 $0.00
86225 0% 24 $0.00
84030 0% 67 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 0% 12 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABSHIRE, KATHRYN (SR VP/CFO)
Parent organizationCHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Same official

Other billing entities under ABSHIRE, KATHRYN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.